Injectable Fillers for Atrophic Acne Scars: A Systematic Review of Mechanisms, Evidence, and Clinical Algorithms

注射填充剂治疗萎缩性痤疮瘢痕:机制、证据和临床算法的系统评价

阅读:1

Abstract

BACKGROUND: Acne affects 9.4% of the global population, with the highest prevalence among adolescent males (12-25 years of age). More than 95% of patients develop persistent scarring, predominantly atrophic acne scars (AAS). These scars markedly impair facial aesthetics, psychological well-being, and quality of life, and increase the risk of depression and suicidal ideation. Conventional therapies (eg, Dermabrasion, Subcision and Traditional Ablative Lasers) show limited efficacy for shallow AAS and are associated with procedural pain, delayed onset of improvement, and a need for repeated sessions. Dermal fillers provide a promising alternative by delivering immediate volumetric correction and aesthetic enhancement while also stimulating long-term collagen production with minimal invasiveness and favorable safety profiles. They therefore represent a novel therapeutic approach for AAS. AIM: This review systematically evaluates the clinical utility of dermal fillers for treating AAS and explores future diagnostic and therapeutic approaches. METHODS: We searched the PubMed and Web of Science databases for studies published in the past 10 years, categorizing and evaluating the efficacy and adverse effects of different dermal fillers for treating AAS. RESULTS: Twenty-four studies met inclusion criteria, involving collagen-based fillers, hyaluronic acid fillers, collagen stimulator fillers, autologous fat, and decellularized matrix fillers. All filler types demonstrated significant scar improvement. Effects ranged from 3-6 months to >24 months. CaHA, PCL, and autologous fat/SVF demonstrated ≥6-month durability. Transient erythema, edema, and ecchymosis were common. Infrequent events included nodules and hyperpigmentation. No severe complications were reported. CONCLUSION: Multiple studies indicate that dermal fillers offer advantages over conventional therapies for atrophic scars. They provide immediate volumetric correction and stimulate long-term collagen production, with less tissue trauma than traditional approaches. Specific formulations also enhance skin hydration and may slow aging processes. Collectively, these benefits demonstrate substantial clinical promise, particularly when incorporated into combination therapies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。